Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cephalexin vs Clindamycin for Pediatric Staph Skin Infections
NCT00352612Phase 4Completed
- Start
- Sep 2006
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of cefalexin and clindamycin in Staphylococcal skin infection, abscess and folliculitis. Primary endpoint: Clinical Improvement at 48-72 Hours. Started Sep 2006; status: completed.
02
Drugs
cefalexinclindamycin
03
Conditions
Staphylococcal skin infectionabscessfolliculitis
Beyond the preview
Go deeper on NCT00352612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00352612.